The SARS-CoV-2 pandemic and its unprecedented global societal and economic disruptive
impact has marked the third zoonotic introduction of a highly pathogenic coronavirus into the …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first reported in late
2019 in China and is the causative agent of the coronavirus disease 2019 (COVID-19) …

An urgent global quest for effective therapies to prevent and treat coronavirus disease 2019
(COVID-19) is ongoing. We previously described REGN-COV2, a cocktail of two potent …

Summary The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) threatens global public health. The …

Abstract In December 2019, coronavirus disease 2019 (COVID-19), which is caused by the
new coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was …

Respiratory disease and increased mortality occurred in minks on two farms in the
Netherlands, with interstitial pneumonia and SARS-CoV-2 RNA in organ and swab samples …

The novel coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is
the cause of COVID-19. The main receptor of SARS-CoV-2, angiotensin I converting enzyme …

Quantitatively describing the time course of the severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) infection within an infected individual is important for …

The current coronavirus disease 2019 (COVID-19) pandemic presents a global public health
challenge. The viral pathogen responsible, severe acute respiratory syndrome coronavirus 2 …

Cytokine release syndrome (CRS) is a major cause of the multi-organ injury and fatal
outcome induced by SARS-CoV-2 infection in severe COVID-19 patients. Metabolism can …